Kevin Wade Kells

Title: Kevin Wade Kells: Innovator in Pharmaceutical Chemistry

Introduction

Kevin Wade Kells is a notable inventor based in Cambridge, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes and compounds. With a total of 2 patents to his name, Kells has demonstrated a commitment to advancing medical science through his inventions.

Latest Patents

Kells' latest patents include groundbreaking work on methods of making lubiprostone and intermediates thereof. This patent outlines processes for preparing Lubiprostone, along with various compounds and intermediates essential for its synthesis. Additionally, he has developed forms of dexlansoprazole and processes for its preparation. This patent details the creation of dexlansoprazole propylene glycolate hydrate and its polymorphic forms, which are crucial for pharmaceutical applications.

Career Highlights

Kevin Wade Kells is currently associated with Apotex Pharmachem Inc., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also advanced the field of drug formulation and development.

Collaborations

Kells has collaborated with talented coworkers such as Fan Wang and Kaarina K Milnes, contributing to a dynamic research environment that fosters innovation and creativity.

Conclusion

Kevin Wade Kells stands out as a significant figure in pharmaceutical innovation, with a focus on developing new methods and compounds that enhance drug efficacy. His contributions are vital to the ongoing advancements in medical science.